| Current Price | $180.96 | Mkt Cap | $10.0B |
|---|---|---|---|
| Open | $181.86 | P/E Ratio | 68.45 |
| Prev. Close | $180.96 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $176.92 - $182.32 | Volume | 507,796 |
| 52-Wk Range | $137.21 - $306.98 | Avg. Daily Vol. | 536,677 |
A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.
| Current Price | $180.96 | Mkt Cap | $10.0B |
|---|---|---|---|
| Open | $181.86 | P/E Ratio | 68.45 |
| Prev. Close | $180.96 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $176.92 - $182.32 | Volume | 507,796 |
| 52-Wk Range | $137.21 - $306.98 | Avg. Daily Vol. | 536,677 |
The best Bull and Bear pitches based on recency and number of recommendations.
RGEN is often taken as a normal biotech. It ain't. It's product is in most cases the raw material, reagent, or quality control for the process used by a biotech company to produce product. And in most cases must be resupplied over time. In effect it… More
These medical corporations tend to have spurts of large growth with long periods of notable decline. Just as Genetic Technologies as been fluctuating over the past year (a range from ~$2.50 - ~$10.00), this company follows a very similar trend. It… More
Read the most recent pitches from players about RGEN.
Recs
TMFMktmusician
(< 20)
Submitted: 1/20/2022 4:17:30 PM :
Start Price:
$148.87
NASDAQ:RGEN Score:
+17.31
https://www.fool.com/investing/2022/01/20/2-healthcare-stocks-that-could-help-set-you-up-for/
Recs
TMFSecurity
(93.49)
Submitted: 11/16/2021 9:08:05 AM :
Start Price:
$260.54
NASDAQ:RGEN Score:
+8.32
10000000146
Recs
daedalian
(< 20)
Submitted: 9/27/2021 5:08:02 PM :
Start Price:
$299.55
NASDAQ:RGEN Score:
-22.22
RGEN is often taken as a normal biotech. It ain't. It's product is in most cases the raw material, reagent, or quality control for the process used by a biotech company to produce product. And in most cases must be resupplied over time. In effect it produces the "blades" for the razors the biotechs produce. The notion changes risk/reward calculus. Evidence history of performance.
Find the members with the highest scoring picks in RGEN.
Stevegoldenfool (< 20) Score: +5,302.87
The Score Leader is the player with the highest score across all their picks in RGEN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Stevegoldenfool | < 20 | 9/26/2011 |
|
5Y | $3.22 | +5,519.88% | +217.01% | +5,302.87 | 0 Comment | |
| TXawlman | 95.10 | 10/26/2006 |
|
5Y | $3.37 | +5,271.33% | +178.54% | +5,092.79 | 1 Comment | |
| toroandbruin | 83.60 | 10/25/2006 |
|
1Y | $3.37 | +5,269.73% | +178.87% | +5,090.87 | 0 Comment | |
| sincroton | < 20 | 8/25/2006 |
|
1Y | $3.36 | +5,285.71% | +198.92% | +5,086.80 | 1 Comment | |
| warbucks52 | < 20 | 8/25/2006 |
|
1Y | $3.36 | +5,285.71% | +199.06% | +5,086.66 | 0 Comment | |
| runic42 | < 20 | 10/2/2006 |
|
1Y | $3.40 | +5,222.35% | +188.83% | +5,033.52 | 0 Comment | |
| Vanter1 | 99.51 | 11/11/2011 |
|
5Y | $3.41 | +5,206.74% | +186.64% | +5,020.10 | 0 Comment | |
| marky985 | < 20 | 10/27/2008 |
|
3Y | $3.32 | +5,350.60% | +330.95% | +5,019.65 | 0 Comment | |
| youmustwhipit | 69.90 | 10/27/2008 |
|
NS | $3.32 | +5,350.60% | +330.95% | +5,019.65 | 0 Comment | |
| wonderpiks | 97.16 | 5/6/2010 |
|
5Y | $3.42 | +5,191.23% | +212.51% | +4,978.72 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
